XML 60 R49.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Statements of Cash Flows (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
As Restated [Member]
Sep. 30, 2012
Parent [Member]
Sep. 30, 2011
Parent [Member]
As Restated [Member]
Sep. 30, 2012
Guarantor Subsidiaries [Member]
Sep. 30, 2011
Guarantor Subsidiaries [Member]
As Restated [Member]
Sep. 30, 2012
Non-Guarantor Subsidiaries [Member]
Sep. 30, 2011
Non-Guarantor Subsidiaries [Member]
As Restated [Member]
Sep. 30, 2012
Consolidation, Eliminations [Member]
Sep. 30, 2011
Consolidation, Eliminations [Member]
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]                    
Net Cash Provided by (Used in) Operating Activities $ 118,154 $ 130,041 [1] $ 1,054 $ 105,089 $ 90,707 $ 20,272 $ 26,393 $ 4,680 $ 0 $ 0
Investing Activities:                    
Change in restricted cash 5,971 (2,293) [1] 0 (26) 5,721 (2,201) 250 (66) 0 0
Purchase of property and equipment (8,875) (7,625) [1] 0 0 (5,044) (5,787) (3,831) (1,838) 0 0
Proceeds from disposal of property and equipment 397 51 [1] 0 0 64 51 333 0 0 0
Net cash (used in) provided by investing activities (2,507) (9,867) [1] 0 (26) 741 (7,937) (3,248) (1,904) 0 0
Financing Activities:                    
Issuance of common stock—equity plans 2,399 5,261 [1] 2,399 5,261 0 0 0 0 0 0
Purchase of treasury stock and other, net (3,270) (5,166) [1] (3,270) (5,166) 0 0 0 0 0 0
Proceeds from bank advances 7,090 0 [1] 0   0   7,090   0  
Debt issuance costs 0 (1,727) [1]   (1,727)   0   0   0
Change in intercompany receivable/payable 0 0 0 0 201 (398) (201) 398 0 0
Net cash (used in) provided by financing activities 6,219 (961) [1] (871) (961) 201 (398) 6,889 398 0 0
Effect of exchange rates on cash and cash equivalents 906 (1,173) [1] 0 0 0 0 906 (1,173) 0 0
Net increase (decrease) in cash and cash equivalent 122,772 118,040 [1] 183 104,102 91,649 11,937 30,940 2,001 0 0
Cash and Cash Equivalents, Beginning of Period 285,512 171,618 [1] 150,171 46,012 93,285 87,619 42,056 37,987 0 0
Cash and Cash Equivalents, End of Period $ 408,284 $ 289,658 [1] $ 150,354 $ 150,114 $ 184,934 $ 99,556 $ 72,996 $ 39,988 $ 0 $ 0
[1] (1) As restated - See Note 14 “Restatement of Previously Issued Financial Statements” of Notes to Condensed Consolidated Financial Statements.See notes to Condensed Consolidated Financial Statements.